Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELTP
$0.25
-0.12%
ELTP
· Elite Pharmaceuticals Inc
$0.25
0.00 (-0.12%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$269.28M
Shares
1.08B
Volume · Oct 21
223.38K
Avg daily vol (3M)
771.66K
All webcasts
Earnings call · FY2024 Q2
Elite Pharmaceuticals Inc (ELTP) Q2 2024 Earnings Call
Revenue
$14.16M
+64.9% YoY
Diluted EPS
$0.01
Gross margin
45.5%
+1.0 pp YoY
Net income
$14.93M
+885.7% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2023 · complete as-filed document